Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2Clinical Perspective by Jonathan Buber,

Slides:

Advertisements

Similar presentations

SUDDEN DEATH IN VARIOUS POPULATIONS: IS GENDER A RISK FACTOR? 11 th International Symposium Heart Failure & Co Reggia di Caserta; April 29, 2011; 12:35.

Advertisements

Alon Barsheshet, MD1, Paul J. Wang, MD2, Arthur J. Moss, MD1, Scott D

LONG-TERM SURVIVAL WITH CARDIAC RESYNCHRONIZATION THERAPY IN MILD HEART FAILURE PATIENTS Ilan Goldenberg, MD, Valentina Kutyifa, MD, PhD, Helmut Klein,

Risk of Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-QT Syndrome and a Normal-Range QTc Ilan Goldenberg, MD,* Samuel Horr,

Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Follow-Up of a Pediatric Cohort With Short.

Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke, 1999–2011CLINICAL PERSPECTIVE by Harlan M. Krumholz, Sharon-Lise T.

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

Improved Survival After Out-of-Hospital Cardiac Arrest and Use of Automated External DefibrillatorsCLINICAL PERSPECTIVE by Marieke T. Blom, Stefanie G.

Relation of Antiphospholipid Antibodies to Postmortem Brain Infarcts in Older PeopleCLINICAL PERSPECTIVE by Zoe Arvanitakis, Robin L. Brey, Jacob H. Rand,

Increased Risk for Heart Valve Disease Associated With Antiphospholipid Antibodies in Patients With Systemic Lupus ErythematosusClinical Perspective by.

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Guide to the Assessment of Physical Activity: Clinical and Research Applications by Scott J. Strath, Leonard A. Kaminsky, Barbara E. Ainsworth, Ulf Ekelund,

Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?Clinical Perspective by Peter J. Schwartz,

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous.

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Journal of Cardiac Failure

American Heart Journal

American Heart Month Resources:

by Michael D. Elliott, Ajoy Kapoor, Michele A. Parker, Dixon B

Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India by Rohina Joshi, Clara K. Chow,

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Circ Cardiovasc Qual Outcomes

Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery.

Circ Cardiovasc Interv

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Sex-Selective QT Prolongation During Rapid Eye Movement Sleep

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of FallotClinical Perspective.

Circ Arrhythm Electrophysiol

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

Effects of Stroke Localization on Cardiac Autonomic Balance and Sudden Death by Sadberk Lale Tokgözoglu, Mustafa Kemal Batur, Mehmet Akif Topçuoglu, Okay.

Exome Sequencing and Systems Biology Converge to Identify Novel Mutations in the L-Type Calcium Channel, CACNA1C, Linked to Autosomal Dominant Long QT.

Behavior and Biology: The Basic Sciences for AHA Action

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Influence of Cardiac Surgeon Report Cards on Patient Referral by Cardiologists in New York State After 20 Years of Public Reporting by David L. Brown,

Contribution of Stroke to the Cochrane Stroke Group Trials Register

Effect of Provider Volume on the Accuracy of Hospital Report Cards

Iatrogenic Adverse Events in the Coronary Care Unit

Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary.

Reflux Esophagitis and the Risk of Stroke in Young Adults

by Nick E. J. West, Peter N. Ruygrok, Clemens M. C. Disco, Mark W. I

Circ Cardiovasc Qual Outcomes

Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,

Cardiovascular Risk Factors and Sequelae in Hypertensive Children Identified by Referral Versus School-Based Screening by Jonathan M. Sorof, Jennifer Turner,

The Process of Rehabilitation and Discharge Planning in Stroke

by Alexander Leaf, Christine M

Increasing Cardiopulmonary Resuscitation Provision in Communities With Low Bystander Cardiopulmonary Resuscitation Rates by Comilla Sasson, Hendrika Meischke,

Estrogen Signaling in the Adrenal Cortex

Menopause and Hypertension

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease by Sten Myrehaug, Melania Pintilie, Lingsong.

Sudden Cardiac Death, Mitral Valve Prolapse, and Long QT Syndrome

Kenshi Hayashi et al. JACEP 2016;2:

Long-Term survival with Cardiac Resynchronization Therapy in Mild Heart Failure patients Ilan Goldenberg, MD, Valentina Kutyifa, MD, PhD, Helmut Klein,

Belinda Gray et al. JCHF 2013;1:

Volume 11, Issue 1, Pages (January 2014)

Volume 15, Issue 1, Pages (January 2018)

Volume 13, Issue 1, Pages (January 2016)

Volume 9, Issue 1, Pages (January 2012)

Fatal Water Intoxication and Cardiac Arrest in Runners During Marathons: Prevention and Treatment Based on Validated Clinical Paradigms Arthur J. Siegel,

Volume 6, Issue 2, Pages (February 2009)

Diagnosis at presentation and diagnoses finally reached at the end of the inpatient admission. Diagnosis at presentation and diagnoses finally reached.

Estrogen and progestogen therapy in postmenopausal women

Distribution of QTc values for patients with and without long QT syndrome (LQTS). Distribution of QTc values for patients with and without long QT syndrome.

Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.

Jenna Barton, MSN, RN-C, PCCN

Presentation transcript:

Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2Clinical Perspective by Jonathan Buber, Jehu Mathew, Arthur J. Moss, W. Jackson Hall, Alon Barsheshet, Scott McNitt, Jennifer L. Robinson, Wojciech Zareba, Michael J. Ackerman, Elizabeth S. Kaufman, David Luria, Michael Eldar, Jeffrey A. Towbin, Michael Vincent, and Ilan Goldenberg Circulation Volume 123(24):2784-2791 June 21, 2011 Copyright © American Heart Association, Inc. All rights reserved.

Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period. Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period. Event rates per 100 person-years among LQT1 and LQT2 women were calculated by dividing the number of events during each menopausal period by the follow-up time in the same period and multiplying the result by 100. Jonathan Buber et al. Circulation. 2011;123:2784-2791 Copyright © American Heart Association, Inc. All rights reserved.

Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period and by estrogen therapy during the postmenopausal period. Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period and by estrogen therapy during the postmenopausal period. Event rates per 100 person-years among LQT1 and LQT2 women were calculated by dividing the number of events each category by the follow-up time in the same category and multiplying the result by 100. Jonathan Buber et al. Circulation. 2011;123:2784-2791 Copyright © American Heart Association, Inc. All rights reserved.